Bifogade filer
Kurs
+3,21%
Likviditet
0,48 MSEK
Kalender
Tid* | ||
2025-06-03 | 07:00 | Bokslutskommuniké 2025 |
2025-03-03 | 07:00 | Kvartalsrapport 2025-Q3 |
2025-01-20 | N/A | Extra Bolagsstämma 2025 |
2024-12-04 | - | Kvartalsrapport 2025-Q2 |
2024-09-26 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2024-09-25 | - | Årsstämma |
2024-08-29 | - | Kvartalsrapport 2025-Q1 |
2024-05-30 | - | Bokslutskommuniké 2024 |
2024-02-29 | - | Kvartalsrapport 2024-Q3 |
2023-12-04 | - | Kvartalsrapport 2024-Q2 |
2023-10-04 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2023-09-27 | - | Årsstämma |
2023-08-31 | - | Kvartalsrapport 2024-Q1 |
2023-06-08 | - | Bokslutskommuniké 2023 |
2023-03-01 | - | Kvartalsrapport 2023-Q3 |
2022-12-01 | - | Kvartalsrapport 2023-Q2 |
2022-10-03 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2022-09-28 | - | Årsstämma |
2022-08-31 | - | Kvartalsrapport 2023-Q1 |
2022-06-10 | - | Bokslutskommuniké 2022 |
2022-03-02 | - | Kvartalsrapport 2022-Q3 |
2021-12-02 | - | Kvartalsrapport 2022-Q2 |
2021-09-09 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2021-09-02 | - | Kvartalsrapport 2022-Q1 |
2021-05-31 | - | Bokslutskommuniké 2021 |
2021-03-03 | - | Kvartalsrapport 2021-Q3 |
2020-12-02 | - | Kvartalsrapport 2021-Q2 |
2020-09-30 | - | Årsstämma |
2020-09-09 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2020-08-24 | - | Kvartalsrapport 2021-Q1 |
2020-06-08 | - | Bokslutskommuniké 2020 |
2020-04-20 | - | Extra Bolagsstämma 2020 |
2020-03-02 | - | Kvartalsrapport 2020-Q3 |
2019-12-02 | - | Kvartalsrapport 2020-Q2 |
2019-09-30 | - | Årsstämma |
2019-09-25 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2019-09-02 | - | Kvartalsrapport 2020-Q1 |
2019-06-10 | - | Bokslutskommuniké 2019 |
2019-03-04 | - | Kvartalsrapport 2019-Q3 |
2018-12-17 | - | Kvartalsrapport 2019-Q2 |
2018-09-25 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2018-09-24 | - | Årsstämma |
2018-09-24 | - | Kvartalsrapport 2019-Q1 |
2018-06-25 | - | Bokslutskommuniké 2018 |
2018-03-26 | - | Kvartalsrapport 2018-Q3 |
2017-12-18 | - | Kvartalsrapport 2018-Q2 |
2017-09-25 | - | Årsstämma |
2017-09-25 | - | Kvartalsrapport 2018-Q1 |
2017-06-30 | - | Bokslutskommuniké 2017 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Mölndal, Sweden, October 27[th], 2022 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announced that the company will provide osseointegrated implant technology to the newly founded Yang Center for Bionics at Massachusetts Institute of Technology (MIT) in the US. Integrum's OPRA[TM ]Implant System and e-OPRA™ will play a key role in the center's research activities.
The recently founded Yang Center for Bionics was established through a donation to the MIT McGovern Institute from philanthropist Lisa Yang. Co-directed by professors Hugh Herr and Edward Boyden, the goal of the center is to develop and deploy enabling technologies that communicate directly with the nervous system to mitigate a broad range of disabilities. The bionic technologies will integrate human physiology with electromechanics.
Integrum's bone-anchored implant systems, OPRA[TM] and e-OPRA[TM], will be important assets for the researchers at the center. The OPRA[TM] Implant System is the only FDA approved bone-anchored treatment system for major limb loss, and e-OPRA[TM] is an upgrade of the system providing a brain-controlled robotic prosthesis. In e-OPRA[TM], the nerves and muscles are interfaced via neuromuscular electrodes to the prosthesis.
The Yang Center for Bionics will unite experts from three MIT schools, and center researchers will collaborate with clinical and surgical collaborators at Harvard Medical School.
More information about the K. Lisa Yang Center for Bionics at MIT can be found here (https://yangtan.mit.edu/k-lisa-yang-center-for-bionics/).
Rickard Brånemark, CEO. +46 (0) 70 846 10 61, E-mail: rickard.branemark@integrum.se
Dennis Baecklund, CFO. +46 (0) 72 556 68 69, E-mail: dennis.baecklund@integrum.se
Certified Adviser
Erik Penser Bank is Certified Adviser and can be reached at +46 (0) 8-463 8000.